These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

497 related articles for article (PubMed ID: 29976291)

  • 21. Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.
    Menon V; Slater JN; White HD; Sleeper LA; Cocke T; Hochman JS
    Am J Med; 2000 Apr; 108(5):374-80. PubMed ID: 10759093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock.
    Udesen NLJ; Helgestad OKL; Banke ABS; Frederiksen PH; Josiassen J; Jensen LO; Schmidt H; Edelman ER; Chang BY; Ravn HB; Møller JE
    Crit Care; 2020 Mar; 24(1):95. PubMed ID: 32188462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation.
    Jakob S
    Shock; 2014 Apr; 41(4):362. PubMed ID: 24632717
    [No Abstract]   [Full Text] [Related]  

  • 24. Norepinephrine and Vasopressin Compared With Norepinephrine and Epinephrine in Adults With Septic Shock.
    Menich BE; Miano TA; Patel GP; Hammond DA
    Ann Pharmacother; 2019 Sep; 53(9):877-885. PubMed ID: 30957512
    [No Abstract]   [Full Text] [Related]  

  • 25. Increasing mean arterial pressure in cardiogenic shock secondary to myocardial infarction: effects on hemodynamics and tissue oxygenation: reply.
    Levy B
    Shock; 2014 Apr; 41(4):362-4. PubMed ID: 24632718
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictors of survival in unselected patients with acute myocardial infarction requiring continuous catecholamine support.
    Schreiber W; Herkner H; Koreny M; Bur A; Hirschl MM; Glogar D; Huber K; Laggner AN
    Resuscitation; 2002 Dec; 55(3):269-76. PubMed ID: 12458064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled study comparing high-dose insulin to vasopressors or combination therapy in a porcine model of refractory propranolol-induced cardiogenic shock.
    Katzung KG; Leroy JM; Boley SP; Stellpflug SJ; Holger JS; Engebretsen KM
    Clin Toxicol (Phila); 2019 Nov; 57(11):1073-1079. PubMed ID: 30806099
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of dopamine and norepinephrine in shock.
    Lee J
    N Engl J Med; 2010 Jun; 362(24):2328-9; author reply 2330-1. PubMed ID: 20560159
    [No Abstract]   [Full Text] [Related]  

  • 29. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?
    Menon V; White H; LeJemtel T; Webb JG; Sleeper LA; Hochman JS
    J Am Coll Cardiol; 2000 Sep; 36(3 Suppl A):1071-6. PubMed ID: 10985707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dopamine versus norepinephrine as the first-line vasopressor in the treatment of cardiogenic shock.
    Na SJ; Yang JH; Ko RE; Chung CR; Cho YH; Choi KH; Kim D; Park TK; Lee JM; Song YB; Choi JO; Hahn JY; Choi SH; Gwon HC
    PLoS One; 2022; 17(11):e0277087. PubMed ID: 36327286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.
    Permpikul C; Tongyoo S; Viarasilpa T; Trainarongsakul T; Chakorn T; Udompanturak S
    Am J Respir Crit Care Med; 2019 May; 199(9):1097-1105. PubMed ID: 30704260
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: a prospective, randomized study.
    Levy B; Bollaert PE; Charpentier C; Nace L; Audibert G; Bauer P; Nabet P; Larcan A
    Intensive Care Med; 1997 Mar; 23(3):282-7. PubMed ID: 9083230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inotrope and vasopressor use in cardiogenic shock: what, when and why?
    Hu K; Mathew R
    Curr Opin Crit Care; 2022 Aug; 28(4):419-425. PubMed ID: 35792520
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dopamine versus norepinephrine in the treatment of shock.
    Nathan Coxford R; Lang E; Dowling S
    CJEM; 2011 Nov; 13(6):395-7. PubMed ID: 22436478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beneficial Effects of Norepinephrine Alone on Cardiovascular Function and Tissue Oxygenation in a Pig Model of Cardiogenic Shock.
    Beurton A; Ducrocq N; Auchet T; Joineau-Groubatch F; Falanga A; Kimmoun A; Girerd N; Fay R; Vanhuyse F; Tran N; Levy B
    Shock; 2016 Aug; 46(2):214-8. PubMed ID: 26849625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Vasopressin versus Norepinephrine in a Pig Model of Refractory Cardiogenic Shock Complicated by Cardiac Arrest and Resuscitated with Veno-arterial ECMO.
    Klein T; Grandmougin D; Liu Y; Orlowski S; Albuisson E; Tran N; Levy B
    Shock; 2021 Sep; 56(3):473-478. PubMed ID: 33555846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of catecholamines in acute myocardial infarction.
    Dixon DW; Loeb HS; Gunnar RM
    Herz; 1979 Oct; 4(5):385-96. PubMed ID: 391685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of shock.
    De Backer D
    Acta Clin Belg; 2011; 66(6):438-42. PubMed ID: 22338308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inotrope versus placebo therapy in cardiogenic shock: Rationale and study design of the CAPITAL DOREMI2 trial.
    Parlow S; Santo PD; Sterling LH; Goodliffe L; Motazedian P; Prosperi-Porta G; Morgan B; Koopman Z; Jung RG; Lepage-Ratte MF; Robinson L; Feagan H; Simard T; Wells GA; Kyeremanteng K; Ainsworth C; Amin F; Marbach JA; Fernando SM; Labinaz M; Belley-Cote EP; Hibbert B; Mathew R
    Am Heart J; 2023 Aug; 262():83-89. PubMed ID: 37094667
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.